Detalles de la búsqueda
1.
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models.
J Neurosci
; 34(28): 9441-54, 2014 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25009275
2.
CD98hc is a target for brain delivery of biotherapeutics.
Nat Commun
; 14(1): 5053, 2023 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598178
3.
Author Correction: CD98hc is a target for brain delivery of biotherapeutics.
Nat Commun
; 14(1): 5516, 2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37679403
4.
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): metabolically stable γ-secretase Inhibitors that selectively inhibit the production of amyloid-ß over Notch.
J Med Chem
; 56(13): 5261-74, 2013 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23713656
Resultados
1 -
4
de 4
1
Próxima >
>>